Proteinuria in newly diagnosed type II diabetic patients

Proteinuria in newly diagnosed type II diabetic patients. M Uusitupa , O Siitonen , I Penttilä , A Aro and K Pyörälä Abstract Urinary excretion of albumin, IgG, and beta 2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and in 144 (62 men,...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 10; no. 2; pp. 191 - 194
Main Authors Uusitupa, Matti, Siitonen, Onni, Penttilä, Ilkka, Aro, Antti, Pyörälä, Kalevi
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.03.1987
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Proteinuria in newly diagnosed type II diabetic patients. M Uusitupa , O Siitonen , I Penttilä , A Aro and K Pyörälä Abstract Urinary excretion of albumin, IgG, and beta 2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and in 144 (62 men, 82 women) nondiabetic control subjects. Both male (N = 57) and female (N = 29) diabetic patients with normal urinary sediment showed an increased excretion of albumin compared with the respective nondiabetic subjects, and male diabetic patients also had an increased IgG excretion. No consistent difference was found in urinary beta 2-microglobulin concentration between the diabetic and nondiabetic subjects. In all, 19.5% of the diabetic subjects with normal urinary sediment (12 men, 5 women) showed urinary albumin concentration exceeding the highest value (35 mg/24 h) found in nondiabetic subjects without renal disease. The urinary excretion of albumin in the diabetic subjects was not associated with the presence of hypertension or coronary heart disease or with the fasting blood glucose or serum insulin levels measured at diagnosis of diabetes. In male diabetic subjects with urinary albumin excretion greater than 35 mg/24 h, a reduced creatinine clearance was found, suggesting the presence of structural damage associated with diabetic nephropathy. The early increase of urinary albumin excretion in type II diabetic patients may be mostly functional in nature. However, some patients may have structural renal damage associated with diabetic nephropathy present at diagnosis.
AbstractList Proteinuria in newly diagnosed type II diabetic patients. M Uusitupa , O Siitonen , I Penttilä , A Aro and K Pyörälä Abstract Urinary excretion of albumin, IgG, and beta 2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and in 144 (62 men, 82 women) nondiabetic control subjects. Both male (N = 57) and female (N = 29) diabetic patients with normal urinary sediment showed an increased excretion of albumin compared with the respective nondiabetic subjects, and male diabetic patients also had an increased IgG excretion. No consistent difference was found in urinary beta 2-microglobulin concentration between the diabetic and nondiabetic subjects. In all, 19.5% of the diabetic subjects with normal urinary sediment (12 men, 5 women) showed urinary albumin concentration exceeding the highest value (35 mg/24 h) found in nondiabetic subjects without renal disease. The urinary excretion of albumin in the diabetic subjects was not associated with the presence of hypertension or coronary heart disease or with the fasting blood glucose or serum insulin levels measured at diagnosis of diabetes. In male diabetic subjects with urinary albumin excretion greater than 35 mg/24 h, a reduced creatinine clearance was found, suggesting the presence of structural damage associated with diabetic nephropathy. The early increase of urinary albumin excretion in type II diabetic patients may be mostly functional in nature. However, some patients may have structural renal damage associated with diabetic nephropathy present at diagnosis.
Urinary excretion of albumin, IgG, and β2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and in 144 (62 men, 82 women) nondiabetic control subjects. Both male (N = 57) and female (N = 29)diabetic patients with normal urinary sediment showed an increased excretion of albumin compared with the respective nondiabetic subjects, and male diabetic patients also had an increased IgG excretion. No consistent difference was found in urinary (β2-microglobulin concentration between the diabetic and nondiabetic subjects. In all, 19.5% of the diabetic subjects with normal urinary sediment (12 men, 5 women) showed urinary albumin concentration exceeding the highest value (35 mg/24 h) found in nondiabetic subjects without renal disease. The urinary excretion of albumin in the diabetic subjects was not associated with the presence of hypertension or coronary heart disease or with thefasting blood glucose or serum insulin levels measured at diagnosis of diabetes. In male diabetic subjects with urinary albumin excretion >35 mg/ 24 h, a reduced creatinine clearance was found, suggesting the presence of structural damage associated with diabetic nephropathy. The early increase of urinary albumin excretion in type II diabetic patients may be mostly functional in nature. However, some patients may have structural renaldamage associated with diabetic nephropathy present at diagnosis.
Urinary excretion of albumin, IgG, and beta 2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and in 144 (62 men, 82 women) nondiabetic control subjects. Both male (N = 57) and female (N = 29) diabetic patients with normal urinary sediment showed an increased excretion of albumin compared with the respective nondiabetic subjects, and male diabetic patients also had an increased IgG excretion. No consistent difference was found in urinary beta 2-microglobulin concentration between the diabetic and nondiabetic subjects. In all, 19.5% of the diabetic subjects with normal urinary sediment (12 men, 5 women) showed urinary albumin concentration exceeding the highest value (35 mg/24 h) found in nondiabetic subjects without renal disease. The urinary excretion of albumin in the diabetic subjects was not associated with the presence of hypertension or coronary heart disease or with the fasting blood glucose or serum insulin levels measured at diagnosis of diabetes. In male diabetic subjects with urinary albumin excretion greater than 35 mg/24 h, a reduced creatinine clearance was found, suggesting the presence of structural damage associated with diabetic nephropathy. The early increase of urinary albumin excretion in type II diabetic patients may be mostly functional in nature. However, some patients may have structural renal damage associated with diabetic nephropathy present at diagnosis.
Author O Siitonen
K Pyörälä
A Aro
M Uusitupa
I Penttilä
Author_xml – sequence: 1
  givenname: Matti
  surname: Uusitupa
  fullname: Uusitupa, Matti
  organization: Departments of Medicine, Kuopio University Central Hospital Kuopio, Finland
– sequence: 2
  givenname: Onni
  surname: Siitonen
  fullname: Siitonen, Onni
  organization: Departments of Medicine, Kuopio University Central Hospital Kuopio, Finland
– sequence: 3
  givenname: Ilkka
  surname: Penttilä
  fullname: Penttilä, Ilkka
  organization: Clinical Chemistry, Kuopio University Central Hospital Kuopio, Finland
– sequence: 4
  givenname: Antti
  surname: Aro
  fullname: Aro, Antti
  organization: Departments of Medicine, Kuopio University Central Hospital Kuopio, Finland
– sequence: 5
  givenname: Kalevi
  surname: Pyörälä
  fullname: Pyörälä, Kalevi
  organization: Departments of Medicine, Kuopio University Central Hospital Kuopio, Finland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/3556105$$D View this record in MEDLINE/PubMed
BookMark eNplkDtPwzAUhS0EKm1hZ0HKhMSQ4mfsjKjiUakSDN0jx75tjVIn2Imq_ntSErEwXZ17HsM3Q5e-9oDQHcELyph8sk4bHWBx1guSkws0JTkTqRBcXaIpJjxPRZ7TazSL8QtjzLlSEzRhQmQEiylSn6FuwfkuOJ04n3g4Vqekn935OoJN2lMDyWp1_pTQOpM0unXg23iDrra6inA73jnavL5slu_p-uNttXxep4ZR1aYZmJwLaZU11BBGS5IboRQzQDhQbglVwgopFJaZLjWYktEMthnjmOqsZHP0MMw2of7uILbFwUUDVaU91F0spBRMZhz3QTwETahjDLAtmuAOOpwKgoszq2Jk9auLnlVfuR-3u_IA9q8wwun9x8Hfu93-6PrqQAHi_60fM8F2EQ
CitedBy_id crossref_primary_10_1002_pdi_1960090409
crossref_primary_10_1111_j_1464_5491_1990_tb01344_x
crossref_primary_10_1016_S1056_8727_97_00045_7
crossref_primary_10_1007_BF00401063
crossref_primary_10_1016_S0272_6386_89_80006_X
crossref_primary_10_2174_1573399818666211117122604
crossref_primary_10_1016_0891_6632_91_90007_C
crossref_primary_10_1016_1056_8727_94_90038_8
crossref_primary_10_2337_diacare_27_7_1716
crossref_primary_10_1111_j_1464_5491_1990_tb01326_x
crossref_primary_10_1007_BF02374492
crossref_primary_10_1007_BF02374491
crossref_primary_10_1007_BF00404802
crossref_primary_10_1111_j_1464_5491_1992_tb01862_x
crossref_primary_10_1007_BF02374493
crossref_primary_10_1016_0002_9343_89_90492_0
crossref_primary_10_1016_1056_8727_94_90033_7
crossref_primary_10_1210_clinem_dgaa661
crossref_primary_10_1007_BF00573497
crossref_primary_10_1016_0891_6632_89_90014_7
crossref_primary_10_1038_ki_1992_127
crossref_primary_10_1016_j_dsx_2018_08_007
crossref_primary_10_1016_S0749_0690_18_30582_2
crossref_primary_10_1007_BF00572545
crossref_primary_10_1016_0272_6386_95_90434_4
crossref_primary_10_1016_S0168_8227_97_00111_3
crossref_primary_10_1111_j_1464_5491_1990_tb01396_x
crossref_primary_10_1016_0168_8227_96_01256_9
crossref_primary_10_1016_S1262_3636_07_80056_5
crossref_primary_10_1016_0168_8227_93_90081_F
crossref_primary_10_1016_S1056_8727_96_00102_X
crossref_primary_10_1111_j_1464_5491_1993_tb00118_x
crossref_primary_10_1007_BF00297452
crossref_primary_10_1093_ptj_84_5_454
crossref_primary_10_1007_BF02374488
crossref_primary_10_1093_ndt_gfn515
crossref_primary_10_1007_s00125_005_1853_9
crossref_primary_10_1007_BF00401144
crossref_primary_10_1093_ndt_gfk009
crossref_primary_10_1016_0891_6632_89_90028_7
crossref_primary_10_1016_0002_9343_88_90405_6
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.2337/diacare.10.2.191
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 194
ExternalDocumentID 10_2337_diacare_10_2_191
3556105
diacare_10_2_191
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
0R
53G
55
5GY
5RE
5RS
AAIKC
AAQQT
AAWTL
AAYJJ
ABFLS
ABOCM
ABPPZ
ABPTK
ACGOD
ACJLH
ACVYA
ADBIT
AENEX
AFDAS
AFFNX
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DU5
ET
F5P
GJ
H13
HZ
IAO
IOF
J5H
KQ8
L7B
M5
O9-
OVD
P2P
RHF
RHI
SV3
TDI
TWZ
VH1
WH7
WOW
X7M
XZ
ZA5
ZGI
ZXP
---
-ET
..I
.55
.GJ
.XZ
08P
0R~
18M
29F
2WC
3O-
3V.
4.4
41~
5VS
6PF
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAKAS
AAMNW
AAQOH
AAYEP
ABUWG
ACGFO
ADBBV
ADZCM
AEGXH
AERZD
AFKRA
AFOSN
AI.
AIAGR
ALIPV
AN0
AQUVI
ATCPS
AZQEC
BAWUL
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BTFSW
BVXVI
C1A
CCPQU
CGR
CUY
CVF
DWQXO
E3Z
EBS
ECM
EDB
EIF
EJD
EMOBN
EX3
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HZ~
IAG
IEA
IGG
IHR
INH
INR
IPO
ITC
K9-
M0K
M0R
M0T
M1P
M2O
M2P
M2Q
M5~
N4W
NAPCQ
NPM
O5R
O5S
OK1
PCD
PEA
PQQKQ
PROAC
PSQYO
Q2X
S0X
SJFOW
TEORI
TR2
UKHRP
VVN
W8F
WHG
WOQ
YHG
YOC
ZCG
~KM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c328t-6ec9457d8dc2c132b19c5883ce14e24d1285d5758076abaecb326ef63402a6b3
ISSN 0149-5992
IngestDate Sat Aug 17 02:00:34 EDT 2024
Fri Aug 23 01:52:52 EDT 2024
Sat Sep 28 08:32:47 EDT 2024
Fri Jan 15 19:48:06 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c328t-6ec9457d8dc2c132b19c5883ce14e24d1285d5758076abaecb326ef63402a6b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 3556105
PQID 77537640
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_77537640
highwire_diabetes_diacare_10_2_191
pubmed_primary_3556105
crossref_primary_10_2337_diacare_10_2_191
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 1987-03-01
PublicationDateYYYYMMDD 1987-03-01
PublicationDate_xml – month: 03
  year: 1987
  text: 1987-03-01
  day: 01
PublicationDecade 1980
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 1987
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
SSID ssj0004488
Score 1.522238
Snippet Proteinuria in newly diagnosed type II diabetic patients. M Uusitupa , O Siitonen , I Penttilä , A Aro and K Pyörälä Abstract Urinary excretion of albumin,...
Urinary excretion of albumin, IgG, and beta 2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and...
Urinary excretion of albumin, IgG, and β2-microglobulin was examined in 132 (69 men, 63 women) newly diagnosed, middle-aged type II diabetic patients and in...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 191
SubjectTerms beta 2-Microglobulin - urine
Blood Glucose - analysis
Creatinine - blood
Creatinine - metabolism
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - metabolism
Female
Humans
Immunoglobulin G - urine
Male
Middle Aged
Proteinuria - complications
Title Proteinuria in newly diagnosed type II diabetic patients
URI http://care.diabetesjournals.org/content/10/2/191.abstract
https://www.ncbi.nlm.nih.gov/pubmed/3556105
https://search.proquest.com/docview/77537640
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZQkRAXVB4VS3lEiAuqvDiOndhHREENqMBhK_UW2YlXirpKKzY5wK9nbMdOumolyiXatZJJ4vn8ZWzPA6F3KpdrseYSN1oQzFhBsVaswAWhNWlqygpXJeL0e35yxr6e8_PJ3dZFl_R6Wf-5Ma7kf7QKbaBXGyV7B81GodAAv0G_cAQNw_GfdPzTJllouwFuZdctgLA2v4HEnPMcGJJ2jnlUlkfe68X6wPskqtu5RXocFl-tD1jo_rNh2_bDlfLRPH3fxoWYtrXZux1V_ei6dmLWDs7auG135nhnc3GhJjRdjokKRkmNj7sD5ol-VnHlUWIufeG6pfFsKTOOwR4R1-iUzGBDZ9yY-rJc42c29bWNdxmcZi4HAIwN-9ZL27KMF86TZe98xKJrIUxqrIxqlFDZ_1Vq8xvcp4Xk1uvzuPw2hc4yV5o0vp3fybYSPuw-w3XLJWSTvn1m4iyU1T56NE4tko8eJ4_RPdM9QQ9OR-eJp0jM4JK0XeLgkkS4JBYuSVkmAS5JgMsztPryefXpBI-FM3CdUdHj3NSS8aIRMNjqNKM6lTUXIqtNygxlDdgkvAE7XZAiV1qZWoMRb9Z5xghVuc4O0F4HWHqOEsaFgSGrBNGGNYZpoPtUE7hESRCtFuh96JPqyqdHqW7TwAK9DZ1WhY2FG056E7qzAqKzu1eqM5fDtioKm3mIkQU68L0cb5jZEq-Ev7jDsxyihxPIX6K9_tdgXoF12evXDh9_AfCheL8
link.rule.ids 315,786,790,27955,27956
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proteinuria+in+Newly+Diagnosed+Type+II+Diabetic+Patients&rft.jtitle=Diabetes+care&rft.au=Uusitupa%2C+Matti&rft.au=Siitonen%2C+Onni&rft.au=Penttil%C3%A4%2C+Ilkka&rft.au=Aro%2C+Antti&rft.date=1987-03-01&rft.issn=0149-5992&rft.eissn=1935-5548&rft.volume=10&rft.issue=2&rft.spage=191&rft.epage=194&rft_id=info:doi/10.2337%2Fdiacare.10.2.191&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_diacare_10_2_191
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon